Blood Diseases Could Show Crisprs Potential as Therapy
b'You know you\\u2019ve struck marketing gold when a brand becomes a so-called \\u201cproprietary eponym.\\u201d Need to blow your nose? Grab a Kleenex. Track some sand from the beach onto your floor? Hoover it up. In biology, Crispr is the proprietary eponym of the moment. The gene-editing technique is so inexpensive and easy to use that, in just four years, it\\u2019s become a ubiquitous tool in labs across the world. And soon, it could jump from bench-top workhorse to human therapeutic.\\nLearn more about your ad choices. Visit podcastchoices.com/adchoices'